The NEUTROGENA brand, founded in 1930 (United States), from 2466 sister brands and 17477 competing brands. NEUTROGENA is owned by JOHNSON & JOHNSON, listed on the stock exchange of New York NEUTROGENA is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
JOHNSON & JOHNSON
(NEUTROGENA)
over 5 years*
USD 152.83